Global Animal Vaccines Market 2014-2018

世界の動物用ワクチン市場:コンパニオンアニマル用/家畜用/豚用/鶏用/馬用ワクチン

◆タイトル:Global Animal Vaccines Market 2014-2018
◆商品コード:IRTNTR4047
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年9月3日
◆ページ数:89
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Five UserUSD3,300 ⇒換算¥369,600見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の動物用ワクチン市場:コンパニオンアニマル用/家畜用/豚用/鶏用/馬用ワクチン"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、製品別分析、技術別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況等の情報をお届けいたします。

About Animal Vaccines
Animal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that can cause a particular disease when in their healthy state. Some of the animal vaccines are also formulated using a part of a microbe’s body such as protein subunits or toxic components. These components act as stimulating agents that trigger the immune system in an animal body. This then prepares the necessary antibodies to act against the microbes present in the body or to destroy any that it encounters in the future. Based on their applications, animal vaccines are predominantly categorized into livestock vaccines, companion vaccines, and aquaculture vaccines.

TechNavio’s analysts forecast the Global Animal Vaccines market to grow at a CAGR of 8.25 percent over the period 2013-2018.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Animal Vaccines market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various animal vaccines. In terms of vaccines types, the Global Animal Vaccines market can be segmented into six: Companion Animal Vaccines, Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Equine Vaccines, and Other Animal Vaccines.

TechNavio’s report, the Global Animal Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Animal Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Bayer HealthCare
• Elanco Animal Health
• Merck Animal Health
• Novartis Animal Health
• Sanofi
• Zoetis

Other Prominent Vendors
• BioCell
• Biogenesis Bago
• Boehringer Ingelheim
• Ceva Santé Animale
• Heska
• Imugene
• Indian Immunologicals
• Lohmann Animal Health International
• Virbac

Market Driver
• Growing Prevalence of Animal Diseases
• For a full, detailed list, view our report

Market Challenge
• Increase in Vaccine Maintenance Costs
• For a full, detailed list, view our report

Market Trend
• Increase in Acquisitions
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Products
07.1 Global Livestock Vaccines Market
07.1.1 Market Size and Forecast
07.2 Global Companion Animal Vaccines Market
07.2.1 Market Size and Forecast
07.3 Global Porcine Vaccines Market
07.3.1 Market Size and Forecast
07.4 Global Poultry Vaccines Market
07.4.1 Market Size and Forecast
07.5 Global Equine Vaccines Market
07.5.1 Market Size and Forecast
07.6 Global Other Animals Vaccines Market
07.6.1 Market Size and Forecast
08. Market Segmentation by Technology
09. Geographical Segmentation
09.1 Animal Vaccines Market in Americas
09.1.1 Market Size and Forecast
09.2 Animal Vaccines Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 Animal Vaccines Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
17.4 Bayer Healthcare
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation by Revenue 2013
17.4.4 Business Segmentation by Revenue 2012 and 2013
17.4.5 Geographical Segmentation by Revenue 2013
17.4.6 Business Strategy
17.4.7 Recent Developments
17.4.8 SWOT Analysis
17.4.9 Strengths
17.4.10 Weaknesses
17.4.11 Opportunities
17.4.12 Threats
17.5 Elanco Animal Health
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Strategy
17.5.4 Recent Developments
17.5.5 SWOT Analysis
17.5.6 Strengths
17.5.7 Weaknesses
17.5.8 Opportunities
17.5.9 Threats
17.6 Merck Animal Health
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Strategy
17.6.4 Recent Developments
17.6.5 SWOT Analysis
17.6.6 Strengths
17.6.7 Weaknesses
17.6.8 Opportunities
17.6.9 Threats
17.7 Novartis Animal Health
17.7.1 Key Facts
17.7.2 Business Overview
17.7.3 Product Segmentation
17.7.4 Geographical Segmentation
17.7.5 Business Strategy
17.7.6 Recent Developments
17.7.7 SWOT Analysis
17.7.8 Strengths
17.7.9 Weaknesses
17.7.10 Opportunities
17.7.11 Threats
17.8 Sanofi
17.8.1 Key Facts
17.8.2 Business Overview
17.8.3 Business Segmentation by Revenue 2013
17.8.4 Business Segmentation by Revenue 2012 and 2013
17.8.5 Geographical Segmentation by Revenue 2013
17.8.6 Business Strategy
17.8.7 Key Developments
17.8.8 SWOT Analysis
17.8.9 Strengths
17.8.10 Weakness
17.8.11 Opportunities
17.8.12 Threats
17.9 Zoetis
17.9.1 Key Facts
17.9.2 Business Overview
17.9.3 Business Segmentation by Revenue 2013
17.9.4 Business Segmentation by Revenue 2012 and 2013
17.9.5 Geographical Segmentation by Revenue 2013
17.9.6 Business Strategy
17.9.7 Recent Developments
17.9.8 SWOT Analysis
17.9.9 Strengths
17.9.10 Weaknesses
17.9.11 Opportunities
17.9.12 Threats

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Animal Vaccines Market 2013-2018 (US$ billion)
Exhibit 3: Global Animal Vaccines Market Segmentation by Product
Exhibit 4: Global Animal Vaccines Market by Market Segmentation 2013
Exhibit 5: Global Livestock Vaccines Market 2013-2018 (US$ billion)
Exhibit 6: Global Companion Animal Vaccines Market 2013-2018 (US$ billion)
Exhibit 7: Global Porcine Vaccines Market 2013-2018 (US$ billion)
Exhibit 8: Global Poultry Vaccines Market 2013-2018 (US$ billion)
Exhibit 9: Global Equine Vaccines Market 2013-2018 (US$ billion)
Exhibit 10: Global Other Animals Vaccines Market 2013-2018 (US$ billion)
Exhibit 11: Global Animal Vaccines Market 2013-2018 (in revenue)
Exhibit 12: Global Animal Vaccines Market 2013-2018 (in percent)
Exhibit 13: Global Animals Vaccines Market Segmentation by Technology
Exhibit 14: Global Animal Vaccines Market by Geographical Segmentation 2013
Exhibit 15: Animal Vaccines Market in Americas 2013-2018 (US$ billion)
Exhibit 16: Animal Vaccines Market in the EMEA Region
Exhibit 17: Animal Vaccines Market in the APAC Region
Exhibit 18: Global Animal Vaccine Market by Geographical Segmentation 2013-2018 (in percent)
Exhibit 19: Zoetis Revenue Segmentation by Geography
Exhibit 20: Zoetis Market Revenue by Species
Exhibit 21: Merck Animal Health by Revenue Segments
Exhibit 22: Sanofi by Revenue Segments
Exhibit 23: Bayer Healthcare: Business Segmentation by Revenue 2013
Exhibit 24: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 25: Bayer Healthcare: Geographical Segmentation by Revenue 2013
Exhibit 26: Novartis Animal Health: Product Segmentation
Exhibit 27: Novartis Animal Health: Geographical Segmentation
Exhibit 28: Sanofi: Business Segmentation by Revenue 2013
Exhibit 29: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 30: Sanofi: Geographical Segmentation by Revenue 2013
Exhibit 31: Zoetis: Business Segmentation by Revenue 2013
Exhibit 32: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 33: Zoetis: Geographical Segmentation by Revenue 2013



【掲載企業】

Bayer HealthCare, Elanco Animal Health, Merck Animal Health, Novartis Animal Health, Sanofi, Zoetis, BioCell, Biogenesis Bago, Boehringer Ingelheim, Ceva Santé Animale, Heska, Imugene, Indian Immunologicals, Lohmann Animal Health International, Virbac

【資料のキーワード】

動物用ワクチン、コンパニオンアニマル用ワクチン、家畜用ワクチン、豚用ワクチン、鶏用ワクチン、馬用ワクチン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の動物用ワクチン市場:コンパニオンアニマル用/家畜用/豚用/鶏用/馬用ワクチン]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆